Press Releases Pharmaron Beijing Co., Ltd.

Equities

300759

CNE100003JW4

End-of-day quote Shenzhen S.E. Other stock markets 23:00:00 25/06/2024 BST			5-day change	1st Jan Change
19.3 ^CNY	+2.82%		-3.31%	-33.40%

06-25	Pharmaron Beijing's Unit Receives Initial Payment for Disposal of Stake in Proteologix	MT
06-21	Johnson & Johnson completed the acquisition of Proteologix, Inc. from Pharmaron Beijing Co., Ltd and other shareholders for approximately $850 million.	CI

Press Releases

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

CORRECTION, Skye Bioscience to Host Virtual Investor Day on October 25, 2023, 'CB1 Axis: Unlocking the Pharmaceutical Potential of the Endocannabinoid System'	23/10/23	AQ
Pharmaron's Liverpool UK Gene Therapy CDMO Commences Major Site Expansion Following UK Government Grant to Support GBP151m Investment	30/03/23	AQ
Pharmaron’s Liverpool UK Gene Therapy CDMO Commences Major Site Expansion Following UK Government Grant to Support £151m Investment	29/03/23	BU
Pharmaron Acquires Commercial API Manufacturing Facility in the United States	24/05/22	BU
Pharmaron Beijing : An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section	24/02/22	PU
Pharmaron Appoints Dr. Antony Davies as Senior Vice President, UK CMC	17/01/22	BU
Pharmaron Acquires Commercial API Manufacturing Facility in the United Kingdom from Recipharm	10/01/22	BU
Pharmaron recognized with 2 Awards at China Securities Golden Bauhinia Awards Ceremony	17/12/21	AQ
Pharmaron Announces Promotion of Ms. Katherine Lee to Chief Business Officer	05/11/21	BU
Pharmaron Beijing : CLOSURE OF REGISTER OF MEMBERS FOR THE FIRST H SHARES CLASS MEETING OF 2021	30/04/21	PU
Pharmaron Beijing : Reply Slip for the First H Shares Class Meeting of 2021	28/04/21	PU
Pharmaron Beijing : Reply Slip for the Annual General Meeting of 2020 (Applicable to H Shareholders)	28/04/21	PU
Pharmaron Beijing : Form of Proxy for the First H Shares Class Meeting of 2021	28/04/21	PU
Pharmaron Beijing : Form of Proxy for the Annual General Meeting of 2020 (Applicable to H Shareholders)	28/04/21	PU
Pharmaron Beijing : NOTICE OF THE FIRST H SHARES CLASS MEETING OF 2021	28/04/21	PU
Pharmaron Beijing : NOTICE OF THE ANNUAL GENERAL MEETING OF 2020	28/04/21	PU
Pharmaron Beijing : REPORT OF BOARD & SUPERVISORY COMMITTEE; FINANCIAL STATEMENTS; PROFIT DISTRIBUTION PLAN; ANNUAL REPORT, REPORT SUMMARY & ANNUAL RESULTS ANNOUNCEMENT; REMUNERATION OF DIRECTORS & SUPERVISORS; ENGAGEMENT OF AUDITORS; GUARANTEES & FOREIGN EXCHANGE HEDGING QUOTA; REPURCHASE & CANCELLATION OF RESTRICTED A SHARES; REDUCTION OF REGISTERED CAPITAL, AMENDMENTS TO THE ARTICLES & REGISTRATION; GRANTING OF GENERAL MANDATE TO ISSUE SHARES; NOTICES OF ANNUAL GENERAL MEETING & 2021 FIRST H SHARES CLASS	28/04/21	PU
Pharmaron Beijing : PROPOSED REDUCTION OF REGISTERED CAPITAL AND PROPOSED AMENDMENTS TO THE ARTICLES OF ASSOCIATION	28/03/21	PU
Pharmaron Beijing : ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED DECEMBER 31, 2020	28/03/21	PU
Pharmaron Beijing : Acquires State-of-the-Art Biomanufacturing Site in the United Kingdom from AbbVie	01/03/21	BU

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Pharmaron Beijing Co., Ltd.

Equities

300759

CNE100003JW4

Press Releases

Filters